(Q51974802)

19 April 2018

title

Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results of a multicenter, double-blind trial. (English)

1 reference

19 April 2018

multicenter clinical trial

main subject

1 reference

Emeriau JP

1

1 reference

19 April 2018

Lehert P

series ordinal

2

1 reference

19 April 2018

Mosnier M

series ordinal

3

1 reference

19 April 2018

publication date

1 July 2000

1 reference

19 April 2018

published in

Clinical Therapeutics

1 reference

19 April 2018

volume

22

1 reference

19 April 2018

issue

7

1 reference

19 April 2018

page(s)

834-844

1 reference

19 April 2018

Dementia with Lewy bodies: review and pharmacotherapeutic implications

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Epidemiology of vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Cerebral blood flow in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Single photon emission computerised tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

A serotonin S2 antagonist, naftidrofuryl, exhibited a protective effect on ischemic neuronal damage in the gerbil

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Involvement of serotonergic neuronal systems in the anti-amnesic action of naftidrofuryl oxalate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Effect of naftidrofuryl oxalate on 5-HT2 receptors in mouse brain: evaluation based on quantitative autoradiography and head-twitch response

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

In vivo effect of naftidrofuryl on 5-hydroxytryptamine-mediated constriction in rat peripheral microcirculation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Naftidrofuryl inhibits the release of 5-hydroxytryptamine and platelet-derived growth factor from human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

The effect of naftidrofuryl on the metabolic response to exercise in man

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Naftidrofuryl, a putative activator of neuron survival, stimulates the expression of neurofilament heavy subunit in cultivated spinal cord neurons from chicken

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Effect of naftidrofuryl on metabolism and survival of cultured neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Naftidrofuryl protects neurons against ischemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Experimental and clinical study of the effect of naftidrofuryl on the recovery from peripheral nerve lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Electrophysiological evaluation of the effects of naftidrofuryl on skeletal muscle reinnervation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Postischemic breakdown in hippocampal protein synthesis and mnesic deficits in rats: Pharmacological improvement by curative naftidrofuryl treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Naftidrofuryl in the treatment of mild senile dementia. A double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Efficacy of naftidrofuryl in patients with moderate senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

1 reference

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980056-9

7 January 2021

10.1016/S0149-2918(00)80056-9

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018